Provided by Tiger Trade Technology Pte. Ltd.

Connect Biopharma Holdings Ltd.

2.36
+0.08003.51%
Post-market: 2.33-0.0300-1.27%19:30 EDT
Volume:444.95K
Turnover:1.03M
Market Cap:148.59M
PE:-1.98
High:2.37
Open:2.30
Low:2.21
Close:2.28
52wk High:3.82
52wk Low:1.23
Shares:62.96M
Float Shares:21.07M
Volume Ratio:1.04
T/O Rate:2.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1933
EPS(LYR):-1.0000
ROE:-140.51%
ROA:-69.75%
PB:5.53
PE(LYR):-2.36

Loading ...

Connect Biopharma Holdings Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 17

Connect Biopharma Holdings Ltd Expected to Post a Loss of 21 Cents a Share - Earnings Preview

Reuters
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)

TIPRANKS
·
Aug 13

Connect Biopharma Hldgs Q2 EPS $(0.27) Beats $(0.31) Estimate, Sales $2.768M Beat $650.000K Estimate

Benzinga Earnings
·
Aug 13

Connect Biopharma - Expects Topline Results from Phase 2 Seabreeze Stat Studies in September 2026

THOMSON REUTERS
·
Aug 13

Press Release: Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 13

Connect Biopharma Posts Investor Presentation Highlighting Rademikibart Program in Asthma, COPD Exacerbations

Reuters
·
Jul 14

Connect Biopharma Holdings Ltd : Oppenheimer Initiates Coverage with Outperform Rating; Target Price $8

THOMSON REUTERS
·
Jul 09

Connect Biopharma Initiated at Overweight by Piper Sandler

Dow Jones
·
Jun 26

Connect Biopharma Holdings Ltd : Piper Sandler Initiates Coverage with Overweight Rating; Target Price $7

THOMSON REUTERS
·
Jun 26

U.S. Research Roundup-american Tower, H.B. Fuller Company, TD Synnex

Reuters
·
Jun 26

Connect Biopharma Price Target Maintained with a $7.00/share by HC Wainwright & Co.

Dow Jones
·
Jun 25

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Alkermes (ALKS) and Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Jun 18

Connect Biopharma Completes Enrollment in Phase 2 Rademikibart Asthma Study

MT Newswires Live
·
Jun 17

Connect Biopharma - to Report Topline Data From Seabreeze Stat Asthma Study in Early September 2026

THOMSON REUTERS
·
Jun 17

Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze Stat Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma

THOMSON REUTERS
·
Jun 17

H.C. Wainwright Reaffirms Their Buy Rating on Connect Biopharma Holdings (CNTB)

TIPRANKS
·
May 27

Canaccord Genuity Initiates Connect Biopharma at Buy With $6 Price Target

MT Newswires Live
·
May 26

Connect Biopharma initiated with a Buy at Canaccord

TIPRANKS
·
May 26

Connect Biopharma Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
May 21